Shares of Indoco Remedies will remain in focus, as the company, in a post-market hours disclosure on Monday, said it has received a nod from the US Food and Drug Administration for its Goa unit. It has a manufacturing capacity of 2.2 billion tablets, 32 million bottles of liquid orals, 16 million tubes of creams and ointments and 60 million capsules of hard gelatin. This brings to a close the USFDA inspection of October 2015.
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.